Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2008 Apr;35(4):420-5.
doi: 10.1111/j.1440-1681.2008.04889.x.

Angiotensin converting enzyme 2 in the kidney

Affiliations
Review

Angiotensin converting enzyme 2 in the kidney

A Koitka et al. Clin Exp Pharmacol Physiol. 2008 Apr.

Abstract

1. Angiotensin converting enzyme 2 (ACE2) is an important homeostatic component of the renin angiotensin system (RAS). ACE2 both degrades the vasoconstrictor, angiotensin II and generates the potent vasodilator peptide, angiotensin 1-7. These actions counterbalance those of ACE. 2. ACE2 is highly expressed in the healthy kidney, particularly in the proximal tubules, where it colocalizes with ACE and angiotensin receptors. 3. Kidney disease and subtotal nephrectomy is associated with a reduction in renal ACE2 expression, possibly facilitating the damaging effects of angiotensin II in the failing kidney. Acquired or genetic ACE2 deficiency also appears to exacerbate renal damage and albuminuria in experimental models, supporting this hypothesis. 4. ACE2 also has an important role in blood pressure control. Many models of hypertension are associated with reduced ACE2 expression. Although ACE2 KO animals are normotensive, in states associated with activation of the RAS, ACE2 overexpression improves blood pressure control and reduces angiotensin responsiveness.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Schematic representation of the proteolytic components of the renin–angiotensin system. ACE, angiotensin converting enzyme; ACE2, angiotensin converting enzyme 2; NEP, neutral endopeptidase‐24.11; PEP, prolyl endopeptidase.
Figure 2
Figure 2
The renal expression of angiotensin converting enzyme 2 (ACE2) in cortical sections from control (a) is modified following the induction of experimental diabetes in male C57Bl6 mice (b). Original magnification ×40.
Figure 3
Figure 3
Expression of angiotensin converting enzyme (ACE) and ACE2 gene as measured by real‐time reverse transcription‐polymerase chain reaction (RT‐PCR) in cortical homogenates from control and diabetic (1 and 32 weeks) Sprague‐Dawley rats. Data are shown as mean percentage control ± SEM; *P < 0.05 versus control.
Figure 4
Figure 4
Gene expression of angiotensin converting enzyme (ACE) and ACE2 gene as measured by real‐time reverse transcription‐polymerase chain reaction (RT‐PCR) in cortical homogenates from control (cnt) and 12‐week subtotal nephrectomized (stnx) Sprague Dawley rats. Data are shown as mean percentage control ± SEM, *P < 0.05 versus control.

References

    1. Crowley SD, Gurley SB, Oliverio MI et al Distinct roles for the kidney and systemic tissues in blood pressure regulation by the renin–angiotensin system. J. Clin. Invest. 2005; 115: 1092–9. - PMC - PubMed
    1. Donoghue M, Hsieh F, Baronas E et al A novel angiotensin‐converting enzyme‐related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1–9. Circ. Res. 2000; 87: E1–9. - PubMed
    1. Turner AJ, Hooper NM. The angiotensin‐converting enzyme gene family: Genomics and pharmacology. Trends Pharmacol. Sci. 2002; 23: 177–83. - PubMed
    1. Rice GI, Thomas DA, Grant PJ, Turner AJ, Hooper NM. Evaluation of angiotensin‐converting enzyme (ACE), its homologue ACE2 and neprilysin in angiotensin peptide metabolism. Biochem. J. 2004; 383: 45–51. - PMC - PubMed
    1. Tipnis SR, Hooper NM, Hyde R, Karran E, Christie G, Turner AJ. A human homolog of angiotensin‐converting enzyme – Cloning and functional expression as a captopril‐insensitive carboxypeptidase. J. Biol. Chem. 2000; 275: 33 238–43. - PubMed

Publication types

Substances